OrganaBio
Christopher B. Goodman is a biopharmaceutical consultant and executive making a global impact in the cellular therapy technology arena. The scope of Christopher’s expertise encompasses Cellular Therapeutic Operations, Quality and Regulatory Affairs, Global Corporate Operations, Scientific Strategic Planning, Scientific R&D Collaborations, and Marketing & Commercialization.
Christopher recently joined OrganaBio as their Vice President of Regulatory Affairs. In this role, Christopher will be helping the company, its clients and its partners navigate the complexities of the domestic and international regulatory requirements governing advanced cellular therapy products and manufacturing.
Previously, Christopher held positions with the Association for the Advancement of Blood and Biotherapies (AABB), Virgin Health Bank, Ventana Medical Systems, and Celgene.
This person is not in any offices
OrganaBio
1 followers
OrganaBio is a CDMO that offers an integrated solution of supply chain, development, and manufacturing resources specifically for cell therapy developers. OrganaBio offers its clients a broad array of expertise across a range of disciplines, including Biomedical Engineering, Cell Biology, Tissue Engineering, Regenerative Medicine, Cell and Gene Therapy, Drug Development, Immunology and Analytical Chemistry.